RNS No 3885q
CAMBRIDGE ANTIBODY TECHNOLOGY
16th July 1998

                  ACQUISITION OF APTEIN INC. CLOSED
                                &
   APPROVAL OF EUROPEAN PATENT FOR POLYSOME DISPLAY RECEIVED

Melbourn, UK:  Cambridge Antibody Technology Group plc (CAT) today announces
that it has closed the deal for the purchase of US company, Aptein Inc. and in
addition Aptein's European patent for its polysome display technology was
granted on 15 July 1998.

The purchase of this US Company, announced on 23 June 1998, provides CAT with
a powerful extension to its existing antibody display technology.  Aptein now
has granted US, European and Australian patents which dominate the field of
polysome display.

For Further Information Contact:
Cambridge Antibody Technology Group Plc
Dr David Chiswell, Chief Executive Officer        Tel: +44 (0) 1763 203233

City/Financial Enquiries
HCC.DeFacto, Nicola How                           Tel: +44 (0) 171 496 3300

Trade/Scientific Press Enquiries
HCC.DeFacto, Andrew Worsfold                      Tel: +44 (0) 1223 518093

END

ACQDQFBFVDKZBKD
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Catco Reinsurance Opport... Charts.
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Catco Reinsurance Opport... Charts.